Smoking, COPD and Chronic Pulmonary Aspergillosis (CPA)
Many people diagnosed with Chronic Pulmonary Aspergillosis (CPA) also have Chronic Obstructive Pulmonary Disease (COPD). One of the strongest shared risk factors between the two conditions is cigarette smoking.
Smoking does not directly “cause” Aspergillus infection in the same way a virus or bacteria causes disease. However, it can create the lung damage and immune dysfunction that make CPA more likely to develop and harder to control.
Why smoking matters in CPA and COPD
Smoking damages the lungs over many years by:
- Destroying normal lung tissue and airways
- Causing chronic inflammation
- Reducing the lungs’ ability to clear mucus, dust and fungal spores
- Damaging the tiny hair-like structures called cilia that normally sweep organisms out of the airways
- Weakening local immune defence inside the lungs
- Increasing emphysema, cavities, scarring and bronchiectasis — all environments where Aspergillus can grow more easily
People breathe in Aspergillus spores every day. Healthy lungs usually remove them without difficulty. Damaged lungs are different. In COPD, especially severe COPD, spores can remain trapped in damaged airways and cavities, increasing the risk of long-term fungal colonisation or infection.
Is smoking causal?
The relationship is complex, but in many patients smoking is likely to be an important contributing cause.
Smoking contributes to:
- COPD development
- Structural lung damage
- Reduced immune clearance
- Increased infection risk
- Faster lung decline
All of these increase vulnerability to CPA.
Smoking is therefore not simply an associated factor. In many patients it is part of the chain of events that eventually leads to CPA developing.
Not every smoker develops CPA, and not every person with CPA has smoked. Some people develop CPA after tuberculosis, severe pneumonia, sarcoidosis, asthma, bronchiectasis, lung surgery or other lung diseases. However, smoking substantially increases risk because it accelerates lung injury and reduces the lungs’ resilience.
Why continuing to smoke after CPA diagnosis is dangerous
Once CPA is established, continuing to smoke can make management much harder.
Smoking may:
- Accelerate further lung destruction
- Worsen breathlessness and cough
- Increase mucus production
- Increase flare-ups and infections
- Reduce physical fitness and oxygen levels
- Reduce quality of life
- Increase hospital admissions
- Make COPD progression faster
- Increase risk of lung cancer alongside CPA
- Make recovery from infections slower
Many patients with CPA already have limited lung reserve. Continuing to smoke can progressively reduce the remaining healthy lung tissue.
“The damage is already done” — is stopping still worthwhile?
Yes. This is one of the commonest and most understandable feelings among long-term smokers with lung disease. However, stopping smoking can still help, even after significant lung damage has already occurred.
Within days to weeks
- Carbon monoxide levels fall
- Oxygen delivery improves
- Airways may become less irritated
- Some coughing and mucus clearance may improve
Within months
- COPD flare-ups may reduce
- Circulation improves
- Physical activity may become easier
- Inflammation begins to reduce
Over years
- Lung function decline slows
- Risk of heart disease and stroke falls
- Risk of lung cancer gradually decreases
- Survival improves compared with continued smoking
For people with CPA, preserving remaining lung function is critical. Slowing further structural damage may help stabilise disease, and antifungal treatment works best in lungs that are not being continually injured by smoke.
Is vaping a safer alternative?
Many patients ask whether vaping, or using e-cigarettes, is a safer option than smoking cigarettes.
Current evidence suggests that vaping is likely to be substantially less harmful than smoking tobacco cigarettes because vaping avoids the combustion process that produces tar, carbon monoxide and many toxic chemicals found in cigarette smoke.
For smokers who are unable to stop nicotine completely, switching entirely from smoking to vaping may reduce harm.
However, vaping is not risk-free.
Vaping aerosols can still irritate the lungs and may contain:
- Fine particles
- Flavouring chemicals
- Heating by-products
- Nicotine
- Other airway irritants
Some people with CPA, COPD, asthma or bronchiectasis report:
- Increased cough
- Throat irritation
- Chest tightness
- Wheeze
- Increased mucus symptoms
Long-term effects of vaping are still being studied.
For patients with CPA, the safest option for lung health is probably:
- Stop smoking cigarettes completely
- Use vaping only if it helps avoid returning to smoking
- Gradually reduce vaping if possible
A common problem is “dual use” — continuing to smoke while also vaping. This usually provides much less benefit than stopping cigarettes completely.
While nicotine itself is addictive, most of the major smoking-related lung damage comes from the toxic products created by burning tobacco.
For many patients, switching from smoking to vaping may still represent an important positive step if it helps them move away from cigarettes permanently.
Nicotine addiction is powerful
Many people with CPA and COPD have smoked for decades. Stopping is rarely simply a matter of willpower. Nicotine is strongly addictive, and smoking often becomes linked to stress relief, routine, anxiety management and social habits.
Patients should not feel ashamed if stopping is difficult. Repeated attempts are normal. Many successful quitters tried several times before succeeding permanently.
What can help?
Support works better than trying alone.
Options include:
- NHS stop smoking services
- Nicotine replacement therapy, such as patches, gum, sprays or lozenges
- Prescription medicines such as varenicline or cytisine, if suitable
- Behavioural support and counselling
- Gradual reduction plans
- Vape or e-cigarette transition strategies in selected patients
- Family and peer support
For many people with severe lung disease, stopping smoking is one of the most important treatments available — alongside inhalers, oxygen, physiotherapy and antifungal medication.
A realistic but important message
Patients with CPA often already live with fatigue, cough, breathlessness and anxiety about the future. Smoking may feel comforting in the short term, but it usually continues the cycle of lung injury that helped create the problem in the first place.
Stopping smoking cannot reverse established CPA, but it may:
- Slow further lung decline
- Improve day-to-day symptoms
- Improve response to treatment
- Preserve independence longer
- Reduce complications
- Improve long-term survival
Even small improvements in lung health can matter enormously when lung reserve is limited.
When to seek medical advice
Patients with CPA, COPD or other lung disease should seek medical advice if they:
- Become significantly more breathless
- Develop chest pain
- Cough up increasing amounts of blood
- Notice worsening wheeze or mucus production
- Develop fevers or signs of infection
- Feel unable to cope with smoking withdrawal symptoms alone
Stopping smoking is often difficult, but healthcare professionals can offer support and treatment options that improve the chances of success.
